Impact of the current guidelines for blood cholesterol management, on eligibility for statin in a sub-saharan african population with type 2 diabetes mellitus
Roger Tankombo1,&, Andre Pascal Kengne1, François Folefack
Kaze1, Noel Désiré Mbango1, Vanessa Balla1,
Henry Namme Luma1, Siméon Pierre Choukem1
1Faculty of Health Sciences, University of Buea, Buea, Cameroon
Roger Tankombo, Faculty of Health Sciences, University of Buea, Buea, Cameroon
the rising global burden of non-communicable diseases (NCDs) is gradually affecting Africa. We aimed to determine the eligibility for statin of people living with type 2 diabetes mellitus (T2DM), using the
2013 American College of Cardiology/American Heart Association (ACC/AHA) and the 2014 United Kingdom, National Institute for Health and Care Excellence (NICE) guidelines.
we analyzed consecutive medical files of patients living with T2DM seen at the outpatient diabetic clinic of the Douala General Hospital-Cameroon between January 2009 and December 2015. Their socio-demographic characteristics, clinical, biochemical and therapeutic data were recorded.
the mean age of the 824 participants (52.8% males) was 56.3±10.3 years. The ACC/AHA and the NICE guidelines assigned 644 (78.2%) and 564 (68.4%) participants respectively, to statin therapy (p
< 0.0001). A total of 487 (75.6%) of those eligible by the ACC/AHA guidelines and 408 (72.3%) of those eligible by the NICE guidelines were not yet on statin, with a weak but significant agreement between the two guidelines (kappa = 0.206, p = 0.0021). An average monthly cost of statin treatment was $23.42 per person corresponding to about 40% of the minimum wage in the country.
following either the ACC/AHA or the NICE guidelines, more than 2/3 of our T2DM patients are eligible for statin therapy, with about 3/4 of them not yet on such therapy. The monthly incurred cost of this treatment approximate about half the minimum wage.
The 3rd Africa Diabetes Congress, Yaounde, Cameroon (Yaounde)
Dates: 19 Apr 17 - 22 Apr 17
Venue: Yaounde Congress Hall
Organizers: Africa Diabetes Congress Limited
Contact person: Prof. Jean Claude Mbanya (email@example.com)